COMETI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 735
EU - Europa 549
AS - Asia 200
OC - Oceania 6
AF - Africa 1
Totale 1.491
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 733
RU - Federazione Russa 268
IT - Italia 110
SG - Singapore 56
HK - Hong Kong 51
SE - Svezia 47
IE - Irlanda 45
CN - Cina 43
PL - Polonia 40
IN - India 20
CH - Svizzera 9
ID - Indonesia 9
JO - Giordania 8
FI - Finlandia 7
AU - Australia 6
VN - Vietnam 6
GB - Regno Unito 5
DE - Germania 4
ES - Italia 4
FR - Francia 4
KR - Corea 4
NL - Olanda 3
CA - Canada 2
IR - Iran 2
UA - Ucraina 2
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
GE - Georgia 1
Totale 1.491
Salva come PNG Salva come JPEG
Città #
Santa Clara 271
Chandler 62
Singapore 48
Fairfield 46
Dublin 45
Ashburn 44
Florence 40
Warsaw 40
Hong Kong 38
Moscow 26
Seattle 22
Cambridge 21
Woodbridge 21
Houston 20
Altamura 17
Lawrence 17
Princeton 14
Mumbai 12
Shanghai 12
Wilmington 12
Buffalo 11
Boston 9
Jakarta 9
Rome 8
Ann Arbor 7
Bern 7
Kent 6
Melbourne 6
Pune 6
Beijing 5
San Diego 5
Barcelona 4
Dong Ket 4
Lauterbourg 4
Medford 4
Scandicci 4
Seoul 4
Yubileyny 4
Boardman 3
Campi Bisenzio 3
Helsinki 3
Dearborn 2
Donoratico 2
Hilversum 2
Ho Chi Minh City 2
London 2
Los Angeles 2
Malmo 2
New York 2
Norwalk 2
Pisa 2
Tehran 2
Turin 2
Washington 2
West Jordan 2
Abidjan 1
Afragola 1
Andover 1
Atlanta 1
Bari 1
Castelliri 1
Chengdu 1
Chiswick 1
Council Bluffs 1
Düsseldorf 1
Elmendorf 1
Falconara Marittima 1
Guangzhou 1
Hefei 1
Hillsboro 1
Hounslow 1
Kunming 1
Lappeenranta 1
Livorno 1
Mascalucia 1
Naples 1
Prague 1
Redmond 1
Redwood City 1
San Pietro di Feletto 1
Sessa Aurunca 1
Soliera 1
Toronto 1
Winnipeg 1
Wuxi 1
Totale 1.002
Salva come PNG Salva come JPEG
Nome #
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 144
Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases 131
Calcinosis in systemic sclerosis: subsets, distribution and complications 131
Treatment options in systemic sclerosis 128
Sclerosi sistemica 91
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 90
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 83
Combination therapy with Bosentan and Sildenafil improves Raynaud’s phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis 82
The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress 81
Oral lactobacillus species in systemic sclerosis 78
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases 75
Stressful life events at the onset and during the evolution of systemic sclerosis 72
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 70
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis 69
ULTRASOUND (US) EVALUATION OF BOWEL VASCULOPATHY IN SYSTEMIC SCLEROSIS (SSC) 69
ORAL MICROBIOME IN RHEUMATIC DISEASES.WHAT INVOLVEMENT? 63
Rheumatic diseases in migrant patients resident in Tuscany: epidemiological data analysis and single-center experience 47
ToRaRI (Tofacitinib in Rheumatoid Arthritis a Real-Life experience in Italy): Effectiveness, safety profile of tofacitinib and concordance between patient-reported outcomes and physician's global assessment of disease activity in a retrospective study in Central-Italy 7
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life 7
Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study 4
Totale 1.522
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.067
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202056 0 0 0 0 0 0 15 11 10 11 8 1
2020/2021118 7 7 3 26 8 20 5 5 12 13 6 6
2021/202284 4 4 4 4 4 6 0 10 4 5 16 23
2022/2023250 21 59 13 17 18 34 27 11 27 2 12 9
2023/2024213 8 17 24 11 17 37 12 37 5 23 16 6
2024/2025724 30 96 65 158 235 116 24 0 0 0 0 0
Totale 1.522